Our Doctors – MD Stem Cells

Posted: April 6, 2019 at 9:44 am

Dr. Levy is the Study Director for the listed studies and should be contacted for more information.

Dr. Levy's interest in leading edge medical technology and advancing medical care is long standing. He developed the first robotic approach to refractive eye surgery in mid 1980s and was actively involved in exploring areas of translational research including nanotechnology for ophthalmic applications. He has lead clinical advances in small incision and topical anesthetic cataract surgery from their inception.

Following a career in the practice of ophthalmology, Dr. Levy transitioned into life science and healthcare business development. Located in Connecticut, he serves as CEO of MD Stem Cells, a leading provider of adult stem cell patient facilitation services and is Study Director for ongoing clinical studies include SCOTS 2, NEST and SciExVR. He is also President of the Acoma Group which provides business development services for biopharmaceutical, medical and healthcare companies globally. Dr. Levy is an Advisory Board member consultant with a leading provider of advice within the clinical and life sciences. He is a reviewer for a molecular science journal with listings on Publon, and serves on the editorial boards of journals in degenerative diseases and ophthalmology.

Read more here:
Our Doctors - MD Stem Cells

Related Post